DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 1.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 31.4. According to RSI analysis, drreddy is weak. 3.0 DRREDDY RSI Chart
MACD (?) MACD: -44.9 and Signal Line: -35.0. According to MACD analysis, drreddy is technically weak. 2.0 DRREDDY MACD Chart
Simple Moving Average (?) According to simple moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 3031.38, 3099.723, 3133.356. 0.0 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 3014.655, 3073.179, 3152.261. 0.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.091. According to bollinger bands, drreddy has recently hit the lower band which is a negative signal. 2.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 3076.2629 and 3129.475. Support level is 2904.0. 2.5 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 52.5 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 21.8 which means DRREDDY is in a trading range and there is no trend. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 23, 2017
Open Price 2939.0
High Price 2959.95
Low Price 2904.0
Close Price 2923.65
Absolute Change -23.75
Percentage Change -0.806%
Weekly Change -2.07%
Monthly Change -2.09%
Yearly Change -0.417%
52-week high 3689.85
52-week low 2750.05
Corporate Actions
ExDate Purpose
July 18, 2016 AGM/DIV-RS 20 PER SHARE
July 10, 2015 AGM/DIV RS 20/- PER SHARE
July 11, 2014 AGM/DIV-RS 18 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.488
Confidence in Beta1.15%
Market Capital Rs. 49871.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 79.15
TTM Price-to-Earnings (P/E) Ratio 36.9
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 23 January 2017: Deliverable Quantity:1.47e+05 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 23 January 2017: Daily Volatility:0.2044 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 23 January 2017: PCR_OI:0.493 PCR:0.509 NA DRREDDY PCR Chart
Premium (?) 23 January 2017 Premium: 4.9 Futures OI:1273600.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 23 January 2017: Price:2923.65 Put with maximum OI:2900.0 Call with maximum OI:3000.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
January 25, 2017 2928.55 1273600.0 2635.0 3684.0 2923.65
February 23, 2017 2940.35 556600.0 1202.0 2090.0 2923.65

Option Chains - NSE

DRREDDY Option Zone

Announcements

January 23, 2017 Dr.Press Release. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 23, 2017, titled "Dr. Reddy's Q3-FY17 Earnings Call Notification".Dr. Reddy's to release Q3 FY17 results on Feb 4, 2017 Earnings call slated for Feb 4, 6.30 PM IST / 8.00 AM EST
January 17, 2017 Dr.Disclosure under SEBI Takeover Regulations. Reddy's Holdings Limited has submitted to the Exchange, vide letter dated January 16, 2017 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 f SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 10, 2017 February 04, 2017 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
October 05, 2016 October 25, 2016 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2016.
See all Board Meetings

DRREDDY is part of...

Index Weightage
NIFTY 1.35
CNX100 1.14
CNX500 0.96
CNXPHARMA 18.7

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 2843 Rs. 2873 Rs. 2898 Rs. 2929 Rs. 2954 Rs. 2985 Rs. 3010